Health

Results: 8077-8088 of 8672

Calliditas Interim Report January - September 2023

BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate

LEQEMBI® Q3 2023 sales published - 0.4 billion yen recorded in the period

Nayo Biotechnology to Unveil New Product A8 Pro at Medica 2023, Empowering Research and Laboratory Efficiency Upgrade

Calliditas Presents Additional Data Analyses from the NefIgArd Phase 3 trial at the American Society of Nephrology (ASN) Kidney Week 2023

PR Newswire associated0

Daewoong Pharmaceutical to Initiate Clinical Trials Early Next Year for Innovative 'GLP-1 Obesity Treatment' with Advanced Microneedle Technology for Sustained Weekly Efficacy

PR Newswire associated0

ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS

PR Newswire associated0

ResoTher Pharma receives a €2.5 million grant from European Innovation Council (EIC) to support a Phase 2a clinical study of their Lead Candidate RTP-026 for Myocardial Infarction

PR Newswire associated0

Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients

Business Wire logo

AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations

Evaxion Shares Latest EVX-01 Phase 2 Clinical Data in Webinar with Key Opinion Leader Adnan Khattak

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer